Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biofrontera (BFRIW) Return on Sales (2020 - 2025)

Historic Return on Sales for Biofrontera (BFRIW) over the last 6 years, with Q3 2025 value amounting to 0.95%.

  • Biofrontera's Return on Sales fell 3200.0% to 0.95% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.47%, marking a year-over-year decrease of 1100.0%. This contributed to the annual value of 0.48% for FY2024, which is 1200.0% up from last year.
  • Latest data reveals that Biofrontera reported Return on Sales of 0.95% as of Q3 2025, which was down 3200.0% from 0.59% recorded in Q2 2025.
  • In the past 5 years, Biofrontera's Return on Sales registered a high of 0.57% during Q1 2022, and its lowest value of 3.69% during Q3 2021.
  • Its 5-year average for Return on Sales is 0.75%, with a median of 0.63% in 2021.
  • In the last 5 years, Biofrontera's Return on Sales plummeted by -27800bps in 2021 and then surged by 31000bps in 2022.
  • Over the past 5 years, Biofrontera's Return on Sales (Quarter) stood at 1.58% in 2021, then soared by 83bps to 0.27% in 2022, then soared by 221bps to 0.33% in 2023, then tumbled by -133bps to 0.11% in 2024, then tumbled by -756bps to 0.95% in 2025.
  • Its last three reported values are 0.95% in Q3 2025, 0.59% for Q2 2025, and 0.49% during Q1 2025.